SHH · 603351.SS
Nanjing Well Pharmaceutical Group Co.,Ltd.
CN¥26.64-CN¥0.41 (-1.52%)
Nanjing Well Pharmaceutical Group Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.51% below the high.
Loading market information…
SHH · 600222.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Henan Taloph Pharmaceutical Stock Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 31.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Henan Taloph Pharmaceutical Stock Co.,Ltd’s forward annual dividend is CN¥0.01 per share, paid annual. The forward yield is 0.22% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Henan Taloph Pharmaceutical Stock Co.,Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Operating from Zhengzhou, China, Henan Taloph Pharmaceutical Stock Co., Ltd. specializes in the research, development, production, and sale of a wide array of Chinese and Western medicines across the nation. The company's product line encompasses various forms, such as oral liquids, tablets, capsules, and injectable fluids. Notable products include Huperzine A tablets, phenoxybenzamine hydrochloride tablets, and pazufloxacin mesylate sodium chloride injections, alongside a selection of other infusion products. Taloph Pharmaceutical serves a diverse client base, including hospitals, pharmacies, and direct consumers. It was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:01 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥26.64-CN¥0.41 (-1.52%)
Nanjing Well Pharmaceutical Group Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 13.51% below the high.
CN¥5.82+CN¥0.02 (+0.34%)
Shandong Wohua Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.29% below the high.
CN¥7.80-CN¥0.42 (-5.11%)
Hainan Shuangcheng Pharmaceuticals Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 37.25% below the high.
CN¥6.69+CN¥0.09 (+1.36%)
Zhejiang Cheng Yi Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 27.0% below the high.
CN¥5.04-CN¥0.26 (-4.91%)
PKU HealthCare Corp.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.92% below the high.
CN¥4.72-CN¥0.11 (-2.28%)
Baotou Dongbao Bio-Tech Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 30.79% below the high.
CN¥14.60-CN¥0.26 (-1.75%)
Tibet AIM Pharm. Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.04% below the high.
CN¥6.50+CN¥0.18 (+2.85%)
Jiangxi Synergy Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.97% below the high.
